Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 7, Pages 3455
Publisher
MDPI AG
Online
2021-03-29
DOI
10.3390/ijms22073455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
- (2021) Matthias Gromeier et al. Nature Communications
- Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
- (2020) Bas Weenink et al. Cancers
- Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma
- (2019) Seçkin Akgül et al. Cancers
- Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial
- (2019) Bas D. Koster et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40
- (2019) Veronika Caisova et al. Cancers
- IMMU-23. TARGETING METASTATIC AND CNS TUMORS VIA MANNAN-BAM, TLR LIGANDS AND ANTI-CD40 ANTIBODY
- (2019) Herui Wang et al. NEURO-ONCOLOGY
- The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
- (2019) Zuzanna Urban-Wojciuk et al. Frontiers in Immunology
- Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis
- (2018) Veronika Caisová et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants
- (2018) Michele Moreau et al. Frontiers in Oncology
- Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine
- (2018) Michaela Wank et al. Cancers
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
- (2017) Juliane Gust et al. Cancer Discovery
- Geographic Variations in the Incidence of Glioblastoma and Prognostic Factors Predictive of Overall Survival in US Adults from 2004–2013
- (2017) Hao Xu et al. Frontiers in Aging Neuroscience
- Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
- (2016) Veronika Caisová et al. BMC CANCER
- Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma
- (2016) W. T. Curry et al. CLINICAL CANCER RESEARCH
- Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
- (2015) A. H. Rook et al. BLOOD
- Heat shock protein vaccines against glioblastoma: from bench to bedside
- (2015) Leonel Ampie et al. JOURNAL OF NEURO-ONCOLOGY
- Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects
- (2014) Hongwei Tian et al. BMC CANCER
- Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials
- (2014) Sufia Butt Hassan et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- The Use of Anchored Agonists of Phagocytic Receptors for Cancer Immunotherapy: B16-F10 Murine Melanoma Model
- (2014) Tereza Janotová et al. PLoS One
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Vaccination with Irradiated Tumor Cells Pulsed with an Adjuvant That Stimulates NKT Cells Is an Effective Treatment for Glioma
- (2012) M. K. Hunn et al. CLINICAL CANCER RESEARCH
- Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
- (2011) M. F. Fransen et al. CLINICAL CANCER RESEARCH
- Fungal Surface and Innate Immune Recognition of Filamentous Fungi
- (2011) Rodrigo T. Figueiredo et al. Frontiers in Microbiology
- TLR-based immune adjuvants
- (2010) Folkert Steinhagen et al. VACCINE
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started